Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprisi… Read more
Nath Bio-Genes (India) Limited (NATHBIOGEN) - Total Assets
Latest total assets as of September 2025: ₹10.14 Billion INR
Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) holds total assets worth ₹10.14 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nath Bio-Genes (India) Limited - Total Assets Trend (2012–2025)
This chart illustrates how Nath Bio-Genes (India) Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nath Bio-Genes (India) Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Nath Bio-Genes (India) Limited's total assets of ₹10.14 Billion consist of 67.2% current assets and 32.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹870.50 Million | 8.7% |
| Accounts Receivable | ₹889.01 Million | 8.7% |
| Inventory | ₹3.38 Billion | 32.9% |
| Property, Plant & Equipment | ₹2.43 Billion | 23.7% |
| Intangible Assets | ₹71.82 Million | 0.7% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Nath Bio-Genes (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nath Bio-Genes (India) Limited's current assets represent 67.2% of total assets in 2025, a decrease from 80.2% in 2012.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2025, up from 2.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 32.9% of total assets.
Nath Bio-Genes (India) Limited Competitors by Total Assets
Key competitors of Nath Bio-Genes (India) Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dongbang Agro
KO:007590
|
Korea | ₩272.67 Billion |
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
Nath Bio-Genes (India) Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nath Bio-Genes (India) Limited generates 0.36x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Nath Bio-Genes (India) Limited generates $ 3.76 in net profit.
Nath Bio-Genes (India) Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.23 | 2.84 | 4.36 |
| Quick Ratio | 1.26 | 1.92 | 2.70 |
| Cash Ratio | 0.00 | 0.01 | 0.00 |
| Working Capital | ₹3.90 Billion | ₹ 3.34 Billion | ₹ 3.54 Billion |
Nath Bio-Genes (India) Limited - Advanced Valuation Insights
This section examines the relationship between Nath Bio-Genes (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.40 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 16.6% |
| Total Assets | ₹10.26 Billion |
| Market Capitalization | $10.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nath Bio-Genes (India) Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Nath Bio-Genes (India) Limited's assets grew by 16.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nath Bio-Genes (India) Limited (2012–2025)
The table below shows the annual total assets of Nath Bio-Genes (India) Limited from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹10.26 Billion | +16.58% |
| 2024-03-31 | ₹8.80 Billion | +11.03% |
| 2023-03-31 | ₹7.93 Billion | +6.86% |
| 2022-03-31 | ₹7.42 Billion | -6.03% |
| 2021-03-31 | ₹7.90 Billion | +8.16% |
| 2020-03-31 | ₹7.30 Billion | +12.98% |
| 2019-03-31 | ₹6.46 Billion | +13.11% |
| 2018-03-31 | ₹5.71 Billion | +97.41% |
| 2017-03-31 | ₹2.89 Billion | +8.49% |
| 2016-03-31 | ₹2.67 Billion | +17.93% |
| 2015-03-31 | ₹2.26 Billion | +19.07% |
| 2014-03-31 | ₹1.90 Billion | +19.99% |
| 2013-03-31 | ₹1.58 Billion | +31.95% |
| 2012-03-31 | ₹1.20 Billion | -- |